MedTrace Logo

Endoscopic Therapy for Bleeding Marginal Ulcers After Gastric Bypass

NCT01040416 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 45

Last updated 2009-12-29

No results posted yet for this study

Summary

The objective of this study is to identify the incidence rate; describe the risk factors, clinical presentation, and endoscopic treatment; assess the morbidity, mortality, and overall performance of the management of patients with actively bleeding marginal ulcers after Roux-en-Y gastric bypass (RYGB) surgery.

Conditions

  • Bleeding Marginal Ulcer

Sponsors & Collaborators

Principal Investigators

  • Francisco M Tercero, MD · Research Associate, University of California San Francisco

  • Kelvin D Higa, MD · Professor of Surgery, University of California San Francisco

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2009-12-31
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01040416 on ClinicalTrials.gov